Study Highlights Benefits of Synbiotics in Rheumatoid Arthritis
Study Overview
Recent research indicates that synbiotics can alleviate symptoms of rheumatoid arthritis (RA). The study found that these supplements help decrease joint pain, lower disease severity scores, and reduce levels of C-reactive protein (CRP) and insulin in affected patients.
Understanding Synbiotics
Synbiotics are dietary supplements that combine probiotics and prebiotics. Probiotics consist of beneficial bacteria often found in fermented foods such as yogurt, kefir, cheese, kimchi, sauerkraut, and fermented soy products. Prebiotics, on the other hand, are plant-based, fiber-rich foods that are fermented in the intestines, promoting the growth of good bacteria.
Rheumatoid Arthritis Explained
Rheumatoid arthritis is a chronic autoimmune disorder characterized by tender and swollen joints due to the immune system attacking the joint lining. Research has shown that the gut microbiota of RA patients differs significantly from that of healthy individuals, particularly with a notable decrease in beneficial bacteria, including Bifidobacterium species and lactic acid bacteria.
Research Methodology
A study published in the British Journal of Nutrition aimed to evaluate the effects of synbiotics on clinical symptoms of rheumatoid arthritis and various inflammatory parameters. Conducted at a hospital in Kashan, Iran, the study involved 54 RA patients aged 25 to 70. Participants were randomly assigned to two groups of 27: one received a synbiotic supplement containing Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, and the prebiotic inulin for eight weeks, while the other group received a placebo with starch.
Assessment Parameters
Before and after the eight-week treatment, the study measured participants’ weights, heights, body mass index (BMI), disease activity scores (DAS-28), and pain levels using a visual analog scale. Additional tests were conducted to assess levels of CRP, nitric oxide, fasting blood glucose, triglycerides, cholesterol (including VLDL, LDL, and HDL), insulin, insulin resistance, beta-cell function, insulin sensitivity, total antioxidant activity, glutathione (GSH), and malondialdehyde.
Study Results
The study results indicated a significant reduction in CRP levels among participants receiving synbiotics. Furthermore, improvements were noted in DAS-28 scores and pain levels. Additionally, synbiotic treatment was associated with increased nitric oxide and GSH levels, reduced insulin levels, and enhanced insulin resistance and beta-cell function. However, no significant changes were observed in cholesterol levels, glucose, or oxidative stress parameters.
Limitations of the Study
One limitation of the research was the lack of verification of patient compliance through stool sample analysis or measurements of short-chain fatty acid levels, which are produced during the fermentation of prebiotic compounds.
Conclusion
The study concludes that synbiotics can effectively reduce symptoms of rheumatoid arthritis, as indicated by improvements in pain and overall disease severity, while also enhancing certain biochemical profiles. However, the precise mechanisms through which synbiotics provide health benefits in RA patients remain unclear and warrant further investigation.
Author Information
Written by: Usha B. Nair, Ph.D.